Imfinzi approved in the US for endometrial cancer

Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy

Lupin and Fuji sign agreement for commercialization of Nextstellis in Vietnam and Philippines

Calquence plus chemoimmunotherapy reduced the risk of disease progression or death by 27%

First and only BTK inhibitor to demonstrate favourable overall survival trend vs. standard-of-care chemoimmunotherapy in this setting

USFDA approves next-gen TKI Augtyro for treatment of solid tumors

Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors

Farxiga approved in the US for the treatment of paediatric type-2 diabetes

Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date

Schneider Electric launches EcoStruxure for life science segment

Accelerating sustainability in Indian pharma industry

Honeywell introduces batch historian to digitalize manufacturing operations

New software solution helps manufacturers digitalize and gain insights from data to increase efficiency

Abbott wins CE mark for dual-chamber leadless pacemaker

Abbott's first-of-its-kind i2i technology enables synchronized communication between two leadless pacemakers

Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing

DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,

Syntegon acquires Telstar

Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth